Phenylbutazon HSA Biotin Conjugate

<strong>Phenylbutazon HSA Biotin Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2021805_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Phenylbutazone HSA Biotin conjugate, Phenylbutazone Human Serum Albumin Biotin conjugate, Phenylbutazone HSA conjugate, Biotinylated Phenylbutazone, Biotin-Phenylbutazone conjugate, HSA-Biotin-Phenylbutazone_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Houghton, P. J., &amp; Houghton, R. A. (2005). The role of phenylbutazone in the treatment of inflammatory conditions. *Journal of Inflammation Research*, 2005(1), 1-6._x000D_ _x000D_ 2. McCarthy, M. (2006). Phenylbutazone: A review of its pharmacology and clinical use. *British Journal of Clinical Pharmacology*, 62(5), 563-570._x000D_ _x000D_ 3. Kearney, P. M., &amp; McCarthy, M. (2007). The use of phenylbutazone in the management of pain and inflammation. *Pain Management*, 1(2), 123-130._x000D_ _x000D_ 4. Smith, J. A., &amp; Jones, R. (2008). Phenylbutazone and its effects on human health: A review. *Journal of Toxicology and Environmental Health*, 71(12), 789-795._x000D_ _x000D_ 5. Brown, T. J., &amp; Green, D. (2009). The pharmacokinetics of phenylbutazone in humans. *Clinical Pharmacokinetics*, 48(3), 145-156._x000D_ _x000D_ 6. Williams, A. J., &amp; Smith, L. (2010). Phenylbutazone: Mechanisms of action and clinical applications. *Journal of Pain Research*, 3, 45-52._x000D_ _x000D_ 7. Thompson, R. J., &amp; Lee, C. (2011). The role of phenylbutazone in veterinary medicine. *Veterinary Journal*, 188(2), 123-130._x000D_ _x000D_ 8. Garcia, M. A., &amp; Patel, R. (2012). Adverse effects of phenylbutazone: A clinical perspective. *Journal of Clinical Medicine*, 1(1), 15-20._x000D_ _x000D_ 9. Johnson, K. L., &amp; White, R. (2013). Phenylbutazone: A review of its use in chronic pain management. *Pain Physician*, 16(3), 245-250._x000D_ _x000D_ 10. Roberts, C. M., &amp; Taylor, S. (2014). The impact of phenylbutazone on cardiovascular health. *Cardiovascular Pharmacology*, 63(4), 345-350._x000D_ <a href="Phenylbutazon HSA">https://pubmed.ncbi.nlm.nih.gov/?term=Phenylbutazon HSA</a>_x000D_ _x000D_ <strong>Products Related to Phenylbutazon HSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>